Florian Perner, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Janus Kinase 2 | 5 | 2022 | 527 | 1.400 |
Why?
|
Leukemia, Myeloid, Acute | 11 | 2023 | 3497 | 1.290 |
Why?
|
Leukemia | 5 | 2023 | 1507 | 1.250 |
Why?
|
Histone-Lysine N-Methyltransferase | 5 | 2023 | 670 | 1.050 |
Why?
|
Y-Box-Binding Protein 1 | 2 | 2021 | 40 | 1.000 |
Why?
|
Gene Expression Regulation, Leukemic | 4 | 2022 | 651 | 0.920 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 5 | 2023 | 282 | 0.740 |
Why?
|
Proto-Oncogene Proteins | 6 | 2023 | 4553 | 0.720 |
Why?
|
Chromatin | 7 | 2023 | 2917 | 0.600 |
Why?
|
Leukemia, Myeloid | 1 | 2020 | 705 | 0.600 |
Why?
|
cdc25 Phosphatases | 1 | 2016 | 62 | 0.580 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2021 | 987 | 0.540 |
Why?
|
fms-Like Tyrosine Kinase 3 | 2 | 2016 | 491 | 0.530 |
Why?
|
Benzimidazoles | 1 | 2020 | 848 | 0.520 |
Why?
|
Hematopoiesis | 2 | 2020 | 2066 | 0.450 |
Why?
|
Myeloproliferative Disorders | 1 | 2019 | 603 | 0.450 |
Why?
|
Bone Marrow | 2 | 2022 | 2941 | 0.430 |
Why?
|
Mutation | 8 | 2023 | 29717 | 0.410 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2023 | 5163 | 0.380 |
Why?
|
Histone Demethylases | 3 | 2022 | 320 | 0.370 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 3800 | 0.350 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 256 | 0.290 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6313 | 0.220 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3557 | 0.220 |
Why?
|
Bone Marrow Examination | 1 | 2022 | 157 | 0.210 |
Why?
|
Histones | 3 | 2021 | 2597 | 0.210 |
Why?
|
Phospholipase C gamma | 1 | 2022 | 128 | 0.200 |
Why?
|
Acetylation | 2 | 2021 | 1085 | 0.190 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2022 | 165 | 0.190 |
Why?
|
Aging | 1 | 2019 | 8626 | 0.180 |
Why?
|
Histone Code | 1 | 2020 | 163 | 0.180 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2022 | 345 | 0.180 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2022 | 1581 | 0.180 |
Why?
|
Inflammation | 1 | 2019 | 10578 | 0.170 |
Why?
|
Jurkat Cells | 1 | 2020 | 742 | 0.170 |
Why?
|
K562 Cells | 1 | 2020 | 632 | 0.170 |
Why?
|
p300-CBP Transcription Factors | 1 | 2019 | 147 | 0.160 |
Why?
|
Drugs, Investigational | 1 | 2020 | 214 | 0.160 |
Why?
|
Mice | 13 | 2023 | 81045 | 0.160 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2019 | 233 | 0.160 |
Why?
|
Animals | 15 | 2023 | 168561 | 0.160 |
Why?
|
Hematopoietic Stem Cells | 2 | 2022 | 3381 | 0.150 |
Why?
|
Neoplasms | 3 | 2022 | 21596 | 0.140 |
Why?
|
Protein Interaction Mapping | 1 | 2020 | 627 | 0.140 |
Why?
|
Tretinoin | 1 | 2019 | 516 | 0.140 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2019 | 707 | 0.140 |
Why?
|
Antineoplastic Agents | 4 | 2023 | 13655 | 0.130 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2015 | 106 | 0.130 |
Why?
|
Proteome | 3 | 2022 | 1790 | 0.130 |
Why?
|
Receptors, Chemokine | 1 | 2018 | 669 | 0.120 |
Why?
|
Kinetics | 1 | 2022 | 6474 | 0.120 |
Why?
|
Apoptosis | 5 | 2021 | 9715 | 0.120 |
Why?
|
Polycythemia Vera | 1 | 2015 | 163 | 0.120 |
Why?
|
Binding Sites | 1 | 2023 | 6115 | 0.120 |
Why?
|
Protein Binding | 2 | 2023 | 9387 | 0.120 |
Why?
|
Neoplastic Stem Cells | 1 | 2022 | 1376 | 0.120 |
Why?
|
Primary Myelofibrosis | 1 | 2015 | 214 | 0.110 |
Why?
|
Proteomics | 2 | 2023 | 3618 | 0.110 |
Why?
|
Staurosporine | 1 | 2014 | 251 | 0.110 |
Why?
|
Prognosis | 3 | 2023 | 29010 | 0.110 |
Why?
|
Benzothiazoles | 1 | 2014 | 247 | 0.110 |
Why?
|
Protein Processing, Post-Translational | 1 | 2021 | 1989 | 0.110 |
Why?
|
Cell Proliferation | 4 | 2021 | 10472 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2020 | 2906 | 0.100 |
Why?
|
Cell Adhesion | 1 | 2018 | 3139 | 0.100 |
Why?
|
Humans | 25 | 2023 | 742088 | 0.100 |
Why?
|
Phenylurea Compounds | 1 | 2014 | 526 | 0.090 |
Why?
|
Epigenesis, Genetic | 2 | 2020 | 3639 | 0.090 |
Why?
|
Leukocytes | 1 | 2018 | 2039 | 0.090 |
Why?
|
Phosphorylation | 2 | 2020 | 8436 | 0.090 |
Why?
|
Cell Lineage | 1 | 2018 | 2504 | 0.090 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2417 | 0.080 |
Why?
|
Methylation | 2 | 2022 | 1107 | 0.080 |
Why?
|
Integrin alpha4beta1 | 2 | 2019 | 121 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2842 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5851 | 0.080 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2018 | 1421 | 0.070 |
Why?
|
Clone Cells | 2 | 2020 | 1692 | 0.070 |
Why?
|
DNA Methylation | 1 | 2020 | 4282 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7721 | 0.070 |
Why?
|
Remission Induction | 2 | 2023 | 2384 | 0.070 |
Why?
|
Cell Movement | 1 | 2018 | 5212 | 0.070 |
Why?
|
Transcription Factors | 5 | 2023 | 12164 | 0.070 |
Why?
|
Gene Rearrangement | 2 | 2022 | 1179 | 0.070 |
Why?
|
Pyrazoles | 1 | 2015 | 1970 | 0.060 |
Why?
|
Parkinson Disease | 1 | 2019 | 2774 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9581 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3691 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 2 | 2019 | 1835 | 0.050 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2022 | 182 | 0.050 |
Why?
|
Ikaros Transcription Factor | 1 | 2022 | 214 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2023 | 16665 | 0.050 |
Why?
|
Gene Expression | 2 | 2023 | 7790 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 12071 | 0.040 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 212 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8425 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2019 | 365 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 316 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2023 | 974 | 0.040 |
Why?
|
Introns | 1 | 2020 | 991 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2019 | 11470 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2020 | 1866 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1135 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2020 | 2085 | 0.040 |
Why?
|
Ubiquitination | 1 | 2021 | 1011 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2020 | 62966 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10163 | 0.030 |
Why?
|
Translocation, Genetic | 1 | 2022 | 1417 | 0.030 |
Why?
|
Phytohemagglutinins | 1 | 2015 | 170 | 0.030 |
Why?
|
RNA Splicing | 1 | 2020 | 907 | 0.030 |
Why?
|
Germ Cells | 1 | 2020 | 628 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2018 | 474 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2018 | 561 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3266 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2020 | 19223 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2020 | 1525 | 0.030 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2015 | 906 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 1363 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2015 | 588 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2022 | 21821 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2020 | 2440 | 0.030 |
Why?
|
Nitriles | 1 | 2015 | 952 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4200 | 0.020 |
Why?
|
Cell Membrane | 1 | 2019 | 3744 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2018 | 5975 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15994 | 0.020 |
Why?
|
Signal Transduction | 2 | 2022 | 23387 | 0.020 |
Why?
|
Male | 5 | 2020 | 349538 | 0.020 |
Why?
|
Antigens, CD | 1 | 2015 | 4024 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 13029 | 0.020 |
Why?
|
Genotype | 1 | 2019 | 12946 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2015 | 5519 | 0.020 |
Why?
|
Female | 5 | 2020 | 379592 | 0.020 |
Why?
|
Pyrimidines | 1 | 2015 | 2933 | 0.010 |
Why?
|
Aged | 3 | 2020 | 162944 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9639 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15194 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18355 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7317 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2015 | 4379 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4438 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5522 | 0.010 |
Why?
|
Adult | 2 | 2020 | 213712 | 0.010 |
Why?
|
Middle Aged | 2 | 2020 | 213127 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57683 | 0.010 |
Why?
|